Infect. Immun., Jun 1997, 2006-2010, Vol 65, No. 6
Copyright © 1997, American Society for Microbiology

Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity

R Lucas, B Echtenacher, E Sablon, P Juillard, S Magez, J Lou, Y Donati, F Bosman, A Van de Voorde, L Fransen, DN Mannel, GE Grau and P de Baetselier
Department of Anesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Switzerland.

In this study, we investigated whether the recently identified lectin- like domain of tumor necrosis factor (TNF) is implicated in its biological activities on mammalian cells. To this end, a mouse TNF (mTNF) triple mutant, T104A-E106A-E109A mTNF (referred to hereafter as triple mTNF), lacking the lectin-like affinity of mTNF for specific oligosaccharides, was compared with the wild-type molecule for various TNF effects in vitro and in vivo. The triple mTNF displayed a 50-fold- reduced TNF receptor 2 (TNFR2)-mediated bioactivity but only a 5-fold- reduced TNFR1-mediated bioactivity in vitro. The specific activity of the triple mutant on L929 fibrosarcoma cells was slightly reduced compared with that of the wild type. We subsequently assessed the systemic toxicity of triple versus wild-type mTNF, since TNFR2 is partially implicated in this activity. The triple mTNF had a significantly reduced toxicity compared with that of wild-type mTNF in vivo. Moreover, we compared the effects of the triple and the wild-type mTNFs in TNFR1-mediated phenomena, such as (i) induction of tolerance towards a lethal mTNF dose and (ii) protective activity in cecal ligation and puncture-induced septic peritonitis. No significant differences between the mutant and wild-type forms were observed. In conclusion, these results indicate that triple mTNF, lacking TNF's lectin-like binding capacity, has reduced systemic toxicity but retains the tolerance-inducing and peritonitis-protective activities of wild- type mTNF.

This article has been cited by other articles:

• Sterns, T., Pollak, N., Echtenacher, B., Mannel, D. N. (2005). Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression. Infect. Immun. 73: 4905-4912 [Abstract] [Full Text]  
• Berthiaume, Y. (2003). Tumor Necrosis Factor and Lung Edema Clearance: The Tip of the Iceberg?. Am. J. Respir. Crit. Care Med. 168: 1022-1023 [Full Text]  
• Elia, N., Tapponnier, M., Matthay, M. A., Hamacher, J., Pache, J.-C., Brundler, M.-A., Totsch, M., De Baetselier, P., Fransen, L., Fukuda, N., Morel, D. R., Lucas, R. (2003). Functional Identification of the Alveolar Edema Reabsorption Activity of Murine Tumor Necrosis Factor-{alpha}. Am. J. Respir. Crit. Care Med. 168: 1043-1050 [Abstract] [Full Text]  
• Echtenacher, B., Mannel, D. N. (2002). Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. Innate Immunity 8: 365-369 [Abstract]  
• Echtenacher, B., Freudenberg, M. A., Jack, R. S., Mannel, D. N. (2001). Differences in Innate Defense Mechanisms in Endotoxemia and Polymicrobial Septic Peritonitis. Infect. Immun. 69: 7271-7276 [Abstract] [Full Text]  
• Fukuda, N., Jayr, C., Lazrak, A., Wang, Y., Lucas, R., Matalon, S., Matthay, M. A. (2001). Mechanisms of TNF-{alpha} stimulation of amiloride-sensitive sodium transport across alveolar epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L1258-L1265 [Abstract] [Full Text]  
• Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S.J., Borlat, F., Sim, B.K.L., Wu, Z., Grau, G.E., Shing, Y., Soff, G.A., Bouck, N., Pepper, M.S. (1998). Multiple Forms of Angiostatin Induce Apoptosis in Endothelial Cells. Blood 92: 4730-4741 [Abstract] [Full Text]